Cardiol Therapeutics (CRDL) Total Debt: 2021

Historic Total Debt for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $5.3 million.

  • Cardiol Therapeutics' Total Debt was N/A to $1.5 million in Q3 2022 from the same period last year, while for Dec 2021 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2021, which is N/A change from last year.
  • As of FY2021, Cardiol Therapeutics' Total Debt stood at $5.3 million.
  • Cardiol Therapeutics' Total Debt's 5-year high stood at $5.3 million during FY2021, with a 5-year trough of $5.3 million in FY2021.
  • Over the past 1 years, Cardiol Therapeutics' median Total Debt value was $5.3 million (recorded in 2021), while the average stood at $5.3 million.